In ovarian cancer, as a transcription factor, Sox2 directly binds to the promoter of ST6Gal-I to drive transcription and increases in N-glycosylated protein α2-6 linked sialic acid, promotes ST6Gal-I and α2-6-linked sialic acid expression, regulates glucose metabolism in cancer cells [97]. Here, ST6GAL1 is linked to cancer.